PROMAC building at Spanish Town Hospital
PROMAC Building at the Bustamante Hospital for Children
The Programme for the Reduction of Maternal and Child Mortality (PROMAC) is spread headed by the Ministry of Health & Wellness which seeks to assist Jamaica in attaining Millennium Development Goal (MDG) 4 "Reducing Child Mortality" and MDG 5 "Improving Maternal Health by reducing the Maternal Mortality Ratios (MMR)" which were goals set for 2015. Although the country made some progress, these targets were not attained and as such have been subsumed under SDG 3 which seeks to ensure health and well-being for all, at every stage of life.
Jamaica has a high prevalence of Non Communicable Diseases (NCDs) such as hypertension, diabetes and obesity. The most common condition leading to a maternal death has been identified as hypertensive disease in pregnancy, which can cause cardiovascular system complications during or soon after labour. Other contributing
factor such as delayed emergency obstetric care has been known to severely impact the outcomes of these women in critical condition.
In seeking to address these challenges, the Programme for the Reduction of Maternal and Child Mortality was developed. Implementation began in 2014 with specific objectives as follows:
To reduce the incidence of neonatal deaths due to inadequate access to high dependency care;
To improve the quality of management of high-risk pregnancies at both secondary and primary health care levels;
To improve the population health seeking behaviour regarding maternal and child health;
To strengthen the institutional capacity of the Ministry of Health Wellness and Regional Health Authorities.
PROMAC is also designed to ensure that mothers and children have access to quality care, through infrastructure improvements; capacity building for health care workers; the promotion of positive health-seeking behaviors; and enabling civil society advocacy for maternal and child health, thus reducing the level of pregnancy-related mortality and morbidity. The HDUs will improve the quality of care for thousands of premature infants and high risk pregnant women.
Funding: The project funding support of approximately €22 million under a Government of Jamaica (GOJ)-European Union (EU) bilateral agreement.